AC Immune SA

ACIU NASDAQ Santé & Biotech Europe CH0329023102
2.22 $
10.12 %

Entreprise biopharmaceutique développant des thérapies contre les maladies neurodégénératives, notamment des vaccins thérapeutiques pour la maladie d'Alzheimer.

Performance & Momentum

6 Months 16.32 %
1 Year 44.31 %
3 Years 1.69 %
5 Years 61.62 %

Similar stocks to AC Immune SA

Anantys Community

Be the first to share your analysis on AC Immune SA.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases